standards > reporting guideline > DOI:10.25504/FAIRsharing.wggn02


ready LINCS Extended Metadata Standard: Nucleic Acid Reagents

Abbreviation:LINCS 2: Nucleic Acid Reagents


General Information
LINCS Production Phase 2 Extended Metadata Standards, including this guideline on Nucleic Acid Reagents, were developed by the LINCS consortium with the goal of generating an integrated view across the diverse LINCS data resources. These guidelines are focused on the minimum required information to model LINCS assays and results and have been recommended by LINCS for adoption beyond the LINCS project.


This record replaces or incorporates the following deprecated resources:

Homepage http://www.lincsproject.org/LINCS/data/standards

Developed in United States

Created in 2016

Taxonomic range




Scope and data types





How to cite this record FAIRsharing.org: LINCS 2: Nucleic Acid Reagents; LINCS Extended Metadata Standard: Nucleic Acid Reagents; DOI: https://doi.org/10.25504/FAIRsharing.wggn02; Last edited: Feb. 22, 2018, 2:16 p.m.; Last accessed: Sep 22 2018 5:29 p.m.


This record is maintained by cchung  ORCID

Record added: March 28, 2017, 7:54 p.m.
Record updated: March 28, 2017, 7:59 p.m. by The FAIRsharing Team.



In Collections


Support

General

Additional Information


Tools

    No tools defined


Schemas

No XSD schemas defined


Access / Retrieve Data

Conditions of Use





Publications

Metadata Standard and Data Exchange Specifications to Describe, Model, and Integrate Complex and Diverse High-Throughput Screening Data from the Library of Integrated Network-based Cellular Signatures (LINCS).

Vempati UD,Chung C,Mader C,Koleti A,Datar N,Vidovic D,Wrobel D,Erickson S,Muhlich JL,Berriz G,Benes CH,Subramanian A,Pillai A,Shamu CE,Schurer SC
J Biomol Screen 2014

View Paper (PubMed) View Publication


Implementing Databases (1)
Library of Integrated Network-Based Cellular Signatures Data Portal
The LINCS Data Portal provides a unified interface for searching LINCS dataset packages and reagents. LINCS data are being made openly available as a community resource through a series of data releases, so as to enable scientists to address a broad range of basic research questions and to facilitate the identification of biological targets for new disease therapies. LINCS datasets consist of assay results from cultured and primary human cells treated with bioactive small molecules, ligands such as growth factors and cytokines, or genetic perturbations. Many different assays are used to monitor cell responses, including assays measuring transcript and protein expression; cell phenotype data are captured by biochemical and imaging readouts. Assays are typically carried out on multiple cell types, and at multiple timepoints; perturbagen activity is monitored at multiple doses.

Implementing Policies

This record is not implemented by any policy.


Credit

Record Maintainer

Funds